Exelon Is Maintained at Equal-Weight by Morgan Stanley
Exelon Analyst Ratings
Morgan Stanley Maintains Exelon(EXC.US) With Hold Rating, Cuts Target Price to $44
Morgan Stanley Cuts Price Target on Exelon to $44 From $46, Maintains Equalweight Rating
Morgan Stanley Sticks to Its Hold Rating for Exelon (EXC)
RBC Capital Maintains Exelon(EXC.US) With Hold Rating, Raises Target Price to $42
RBC Capital Sticks to Its Hold Rating for Exelon (EXC)
RBC Capital Adjusts Exelon Price Target to $42 From $40, Maintains Sector Perform Rating
BMO Capital Maintains Exelon(EXC.US) With Buy Rating, Raises Target Price to $46
Evercore Maintains Exelon(EXC.US) With Hold Rating, Cuts Target Price to $43
Scotiabank Maintains Exelon(EXC.US) With Hold Rating, Raises Target Price to $40
Wells Fargo Maintains Exelon(EXC.US) With Hold Rating, Raises Target Price to $43
Evercore ISI Adjusts Exelo's Price Target to $43 From $42, Keeps In Line Rating
J.P. Morgan Maintains Exelon(EXC.US) With Hold Rating, Raises Target Price to $44
Wolfe Research Adjusts Price Target on Exelon to $47 From $43, Maintains Outperform Rating
Morgan Stanley Maintains Exelon(EXC.US) With Hold Rating, Raises Target Price to $46
Morgan Stanley Remains a Hold on Exelon (EXC)
Exelon (EXC) Receives a Hold From Scotiabank
Exelon Is Maintained at Overweight by Barclays
Exelon Analyst Ratings